COVID-19 has wrought shutdowns and thousands of global deaths for almost six months. People are anxiously waiting for the chance to return to normal routines. Vaccines may bring that hope. Many companies have joined the race and began the development of COVID-19 vaccines. Some frontrunners have entered clinical trials. What are the differences between these vaccines? How to develop a vaccine in such a short time, and what can we learn from this COVID-19 pandemic? Join us in this webinar. Dr. Li will answer these questions and share experiences on vaccine development strategies!

Speaker: Dr. Hangwen Li is the founder, President and CEO of Stemirna Therapeutics. Dr. Li has over 20 years of experience in cancer research and treatment. His areas of interest include immunotherapy, RNA therapeutics and cancer stem cells. Dr. Li’s published articles have been cited more than 2,000 times. Dr. Li received his Ph.D. degree from the University of Texas M.D. Anderson Cancer Center.